Published in J Clin Microbiol on December 01, 1985
Impact of Daily Bathing With Chlorhexidine in the Critical Patient | NCT02870062
The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol (1999) 7.19
The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol (1996) 5.82
Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev (1994) 5.77
Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev (1988) 5.13
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother (2002) 4.83
The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci U S A (2007) 4.07
Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation. Infect Immun (1996) 3.95
Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun (1997) 3.71
Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect Immun (1992) 3.68
Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol (2004) 3.58
Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J Bacteriol (2004) 3.39
Growing and analyzing static biofilms. Curr Protoc Microbiol (2005) 2.91
Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress. J Bacteriol (2001) 2.89
Alternative transcription factor sigma(B) is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J Bacteriol (2000) 2.78
Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect Immun (2004) 2.69
A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect Immun (1997) 2.65
Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol (2001) 2.63
A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus. J Bacteriol (2000) 2.60
Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother (2000) 2.55
A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol (2008) 2.51
From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev (2008) 2.47
icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis. J Bacteriol (2002) 2.43
Phenotypic variation of Staphylococcus epidermidis slime production in vitro and in vivo. Infect Immun (1987) 2.29
Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun (2005) 2.04
Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev (1993) 2.02
Isolation and characterization of transposon mutants of Staphylococcus epidermidis deficient in capsular polysaccharide/adhesin and slime. Infect Immun (1993) 1.99
Hemolysins and other characteristics that help differentiate and biotype Staphylococcus lugdunensis and Staphylococcus schleiferi. J Clin Microbiol (1990) 1.97
Identification of an antigenic marker of slime production for Staphylococcus epidermidis. Infect Immun (1990) 1.95
Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol (2007) 1.89
Biotyping coagulase-negative staphylococci. J Clin Microbiol (1988) 1.82
Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect Immun (2005) 1.78
The ica operon and biofilm production in coagulase-negative Staphylococci associated with carriage and disease in a neonatal intensive care unit. J Clin Microbiol (2002) 1.77
Methicillin resistance alters the biofilm phenotype and attenuates virulence in Staphylococcus aureus device-associated infections. PLoS Pathog (2012) 1.72
Streptococcus parasanguis fimbria-associated adhesin fap1 is required for biofilm formation. Infect Immun (2001) 1.71
A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proc Natl Acad Sci U S A (2008) 1.70
Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother (2003) 1.69
Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect Immun (2010) 1.66
Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother (2009) 1.62
Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother (2005) 1.61
RsbU-dependent regulation of Staphylococcus epidermidis biofilm formation is mediated via the alternative sigma factor sigmaB by repression of the negative regulator gene icaR. Infect Immun (2004) 1.57
Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother (1995) 1.57
Pigment gallstones form as a composite of bacterial microcolonies and pigment solids. Ann Surg (1987) 1.55
Phenotypic variation of Staphylococcus epidermidis isolated from a patient with native valve endocarditis. J Clin Microbiol (1992) 1.54
Essential functional role of the polysaccharide intercellular adhesin of Staphylococcus epidermidis in hemagglutination. Infect Immun (1999) 1.51
Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis. Infect Immun (2006) 1.51
Adherence measured by microtiter assay as a virulence marker for Staphylococcus epidermidis infections. J Clin Microbiol (1990) 1.50
Identification of three essential regulatory gene loci governing expression of Staphylococcus epidermidis polysaccharide intercellular adhesin and biofilm formation. Infect Immun (2000) 1.48
Glucose-related dissociation between icaADBC transcription and biofilm expression by Staphylococcus epidermidis: evidence for an additional factor required for polysaccharide intercellular adhesin synthesis. J Bacteriol (2003) 1.47
Hemagglutination and adherence to plastic by Staphylococcus epidermidis. Infect Immun (1992) 1.47
Ultrastructural organization and regulation of a biomaterial adhesin of Staphylococcus epidermidis. J Bacteriol (1996) 1.46
Regulation of slime production in Staphylococcus epidermidis by iron limitation. Infect Immun (1993) 1.45
Effects of extracts from Italian medicinal plants on planktonic growth, biofilm formation and adherence of methicillin-resistant Staphylococcus aureus. J Ethnopharmacol (2008) 1.39
Detection of differential gene expression in biofilm-forming versus planktonic populations of Staphylococcus aureus using micro-representational-difference analysis. Appl Environ Microbiol (2001) 1.38
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother (2006) 1.37
Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl Environ Microbiol (2006) 1.37
Phenotypic variation of Staphylococcus epidermidis in infection of transvenous endocardial pacemaker electrodes. J Clin Microbiol (1990) 1.37
Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun (2007) 1.35
Biofilm formation by Staphylococcus haemolyticus. J Clin Microbiol (2009) 1.35
Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection. PLoS One (2013) 1.32
Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother (2004) 1.31
The Staphylococcus aureus LytSR two-component regulatory system affects biofilm formation. J Bacteriol (2009) 1.31
Role of the Staphylococcus epidermidis slime layer in experimental tunnel tract infections. Infect Immun (1992) 1.30
Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis (2013) 1.30
Biofilm formation and the presence of the intercellular adhesion locus ica among staphylococci from food and food processing environments. Appl Environ Microbiol (2003) 1.29
In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Chemother (2003) 1.28
Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime. Antimicrob Agents Chemother (2004) 1.23
Lack of mecA transcription in slime-negative phase variants of methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother (1994) 1.21
Association of coagulase-negative staphylococcal slime production and adherence with the development and outcome of adult septicemias. J Clin Microbiol (1990) 1.18
Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J Clin Microbiol (2006) 1.18
Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenes. PLoS One (2009) 1.18
A study of phenotypic variation of Staphylococcus epidermidis using Congo red agar. Epidemiol Infect (1992) 1.17
Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol (2007) 1.16
Modulation of biofilms of Pseudomonas aeruginosa by quinolones. Antimicrob Agents Chemother (1995) 1.16
Chemical modification of reactive multilayered films fabricated from poly(2-alkenyl azlactone)s: design of surfaces that prevent or promote mammalian cell adhesion and bacterial biofilm growth. Biomacromolecules (2009) 1.15
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections. Pathogens (2013) 1.15
Quorum-sensing mutations affect attachment and stability of Burkholderia cenocepacia biofilms. Appl Environ Microbiol (2005) 1.13
Purification and characterization of the staphylococcal slime-associated antigen and its occurrence among Staphylococcus epidermis clinical isolates. Infect Immun (1996) 1.13
Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin. Antimicrob Agents Chemother (2001) 1.12
Production of extra-cellular slime by Staphylococcus epidermidis during stationary phase of growth: its association with adherence to implantable devices. J Clin Pathol (1990) 1.09
Expression of slime interferes with in vitro detection of host protein receptors of Staphylococcus epidermidis. Infect Immun (1997) 1.08
Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria. Nanoscale Res Lett (2014) 1.08
Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis. PLoS One (2010) 1.07
Conversion of Staphylococcus epidermidis strains from commensal to invasive by expression of the ica locus encoding production of biofilm exopolysaccharide. Infect Immun (2005) 1.06
Furanone at subinhibitory concentrations enhances staphylococcal biofilm formation by luxS repression. Antimicrob Agents Chemother (2009) 1.06
Extracellular DNA-dependent biofilm formation by Staphylococcus epidermidis RP62A in response to subminimal inhibitory concentrations of antibiotics. Res Microbiol (2011) 1.06
Effects of subinhibitory concentrations of vancomycin and teicoplanin on adherence of staphylococci to tissue culture plates. Antimicrob Agents Chemother (1993) 1.05
Development of a standard test to assess the resistance of Staphylococcus aureus biofilm cells to disinfectants. Appl Environ Microbiol (2002) 1.05
Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob Agents Chemother (2007) 1.05
Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein. J Bacteriol (2007) 1.04
Role of the SaeRS two-component regulatory system in Staphylococcus epidermidis autolysis and biofilm formation. BMC Microbiol (2011) 1.02
Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein. Infect Immun (2009) 1.02
Differential expression of methicillin resistance by different biofilm-negative Staphylococcus epidermidis transposon mutant classes. Antimicrob Agents Chemother (2002) 1.01
Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation. Ann Clin Microbiol Antimicrob (2010) 1.01
Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates. Infect Immun (2007) 1.01
Comparison of methods for the detection of biofilm production in coagulase-negative staphylococci. BMC Res Notes (2010) 1.01
Species identification, antibiotic sensitivity and slime production of coagulase-negative staphylococci isolated from clinical specimens. Epidemiol Infect (1988) 1.00
Prevalence of the ica operon and insertion sequence IS256 among Staphylococcus epidermidis prosthetic joint infection isolates. Eur J Clin Microbiol Infect Dis (2008) 1.00
Characterization of IcmF of the type VI secretion system in an avian pathogenic Escherichia coli (APEC) strain. Microbiology (2011) 0.99
A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med (1977) 11.49
Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun (1982) 9.97
Natural populations of the genus Staphylococcus. Annu Rev Microbiol (1980) 5.63
Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis (1982) 5.40
Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med (1982) 5.03
Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol (1983) 4.40
Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J Clin Microbiol (1984) 3.88
The effects of proteins on bacterial attachment to polystyrene. J Gen Microbiol (1976) 3.75
Staphylococcus epidermidis infections. Ann Intern Med (1983) 3.57
Microbial colonization of prosthetic devices. II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 3.53
Excessive production of mucoid substance in staphylococcus SIIA: a possible factor in colonisation of Holter shunts. Dev Med Child Neurol Suppl (1972) 3.14
Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun (1983) 2.85
Streptococcus mutans adherence: presumptive evidence for protein-mediated attachment followed by glucan-dependent cellular accumulation. Infect Immun (1980) 2.58
Scanning electron microscopy of bacteria adherent to intravascular catheters. J Clin Microbiol (1984) 2.56
Production of experimental endocarditis by coagulase-negative staphylococci: variability in species virulence. J Infect Dis (1984) 2.17
Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. J Clin Microbiol (1983) 2.13
Microbial colonization of prosthetic devices. III. Adhesion of staphylococci to lumina of intravenous catheters perfused with bacterial suspensions. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 1.97
Microbial colonization of prosthetic devices. I. Microtopographical characteristics of intravenous catheters as detected by scanning electron microscopy. Zentralbl Bakteriol Mikrobiol Hyg B (1981) 1.95
Adhesion of coagulase-negative staphylococci to biomaterials. J Gen Microbiol (1983) 1.85
In vitro quantitative adherence of bacteria to intravascular catheters. J Surg Res (1983) 1.77
Investigations on staphylococcal infection of transvenous endocardial pacemaker electrodes. Am Heart J (1984) 1.63
Incidence, adherence, and antibiotic resistance of coagulase-negative Staphylococcus species causing human disease. Diagn Microbiol Infect Dis (1984) 1.61
Attachment of staphylococci to various synthetic polymers. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.48
Morphology of bacterial attachment to cardiac pacemaker leads and power packs. J Clin Microbiol (1984) 1.48
Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J Infect Dis (1981) 14.19
Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun (1982) 9.97
Transmission of group B streptococci among parturient women and their neonates. J Pediatr (1973) 6.86
Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr (1973) 6.29
Mannose binding and epithelial cell adherence of Escherichia coli. Infect Immun (1978) 5.99
Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med (1976) 5.55
Cell membrane-binding properties of group A streptococcal lipoteichoic acid. J Exp Med (1975) 5.30
Nosocomial septicemia due to multiply antibiotic-resistant Staphylococcus epidermidis. Ann Intern Med (1982) 5.03
Selective broth medium for isolation of group B streptococci. Appl Microbiol (1973) 4.42
Characterization of clinically significant strains of coagulase-negative staphylococci. J Clin Microbiol (1983) 4.40
Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med (1968) 4.38
Resistance of Neisseria gonorrhoeae to phagocytosis: relationship to colonial morphology and surface pili. J Infect Dis (1974) 4.15
Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J (1992) 3.84
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Group B streptococcal infections in infants. The importance of the various serotypes. JAMA (1974) 3.71
Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen. J Exp Med (1977) 3.62
Primary structure of protective antigens of type 24 streptococcal M protein. J Biol Chem (1980) 3.39
Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein. Nature (1981) 3.38
Adherence of group A streptococci to fibronectin on oral epithelial cells. Infect Immun (1983) 3.11
Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome. J Infect Dis (1987) 3.09
The genetic determinant of adhesive function in type 1 fimbriae of Escherichia coli is distinct from the gene encoding the fimbrial subunit. J Bacteriol (1986) 2.93
Repeating covalent structure of streptococcal M protein. Proc Natl Acad Sci U S A (1978) 2.89
Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun (1983) 2.85
Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med (1982) 2.84
Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital. Appl Microbiol (1970) 2.83
Multiple, heart-cross-reactive epitopes of streptococcal M proteins. J Exp Med (1985) 2.61
Toxic effects of streptococcal M protein on platelets and polymorphonuclear leukocytes in human blood. J Exp Med (1971) 2.59
Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med (1985) 2.53
Adherence of streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells. Infect Immun (1983) 2.48
A 12 year review of the antibiotic management of Hemophilus influenzae meningitis. Comparison of ampicillin and conventional therapy including chloramphenicol. J Pediatr (1972) 2.48
Excretion of lipoteichoic acid by group A streptococci. Influence of penicillin on excretion and loss of ability to adhere to human oral mucosal cells. J Clin Invest (1978) 2.40
Binding of group A streptococci to human oral mucosal cells by lipoteichoic acid. Trans Assoc Am Physicians (1975) 2.32
Phenotypic variation of Staphylococcus epidermidis slime production in vitro and in vivo. Infect Immun (1987) 2.29
Identification of two ancillary subunits of Escherichia coli type 1 fimbriae by using antibodies against synthetic oligopeptides of fim gene products. J Bacteriol (1987) 2.26
Delayed hypersensitivity to purified streptococcal m protein in guinea pigs and in man. J Immunol (1969) 2.25
Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. Nature (1988) 2.24
Formation of molecular complexes between a structurally defined M protein and acylated or deacylated lipoteichoic acid of Streptococcus pyogenes. J Bacteriol (1982) 2.22
Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest (1982) 2.19
Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin. Infect Immun (1974) 2.18
Production of experimental endocarditis by coagulase-negative staphylococci: variability in species virulence. J Infect Dis (1984) 2.17
Colonial morphology of staphylococci on Memphis agar: phase variation of slime production, resistance to beta-lactam antibiotics, and virulence. J Infect Dis (1990) 2.17
Laboratory and pharmacologic studies of BL-P-1322 (cephapirin sodium) in children. Curr Ther Res Clin Exp (1971) 2.17
Adherence pharyngeal and skin strains of group A streptococci to human skin and oral epithelial cells. Infect Immun (1977) 2.17
Type-specific inhibition of preopsonization versus immunoprecipitation by Streptococcal M proteins. Infect Immun (1973) 2.13
Infections and antibiotic use among patients at Boston City Hospital, February, 1967. N Engl J Med (1968) 2.12
Interference with the mannose binding and epithelial cell adherence of Escherichia coli by sublethal concentrations of streptomycin. J Clin Invest (1979) 2.10
Clinical predictors of recurrent Clostridium difficile infection in out-patients. Aliment Pharmacol Ther (2014) 2.08
Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages. Infect Immun (1981) 2.03
Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci. J Exp Med (1980) 2.00
Induction of delayed hypersensitivity to influenza and mumps viruses in mice. J Immunol (1969) 1.99
Fibronectin-mediated binding of group A streptococci to human polymorphonuclear leukocytes. Infect Immun (1982) 1.99
Antiadhesive properties of a quaternary structure-specific hybridoma antibody against type 1 fimbriae of Escherichia coli. J Exp Med (1983) 1.96
Bacteremia due to serratia marcescens. N Engl J Med (1968) 1.96
Identification of an antigenic marker of slime production for Staphylococcus epidermidis. Infect Immun (1990) 1.95
Seasonal variation in Escherichia coli bloodstream infection: a population-based study. Clin Microbiol Infect (2009) 1.88
Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis (2007) 1.87
Molecular evolution of streptococcal M protein: cloning and nucleotide sequence of the type 24 M protein gene and relation to other genes of Streptococcus pyogenes. J Bacteriol (1988) 1.86
Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein. J Exp Med (1983) 1.82
Bacterial adherence. Adv Intern Med (1980) 1.80
Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci. J Bacteriol (1985) 1.77
Adherence of Streptococcus sanguis to conformationally specific determinants in fibronectin. Infect Immun (1988) 1.77
Binding of streptococcal lipoteichoic acid to the fatty acid binding sites on serum albumin. J Biol Chem (1980) 1.75
Mediation of cytotoxic effects of streptococcal M protein by nontype-specific antibody in human sera. J Clin Invest (1973) 1.74
Peptic digestion of streptococcal M protein. I. Effect of digestion at suboptimal pH upon the biological and immunochemical properties of purified M protein extracts. Infect Immun (1974) 1.74
Studies of antibodies to non-type-specific antigens associated with streptococcal M protein in the sera of patients with rheumatic fever. J Immunol (1973) 1.73
Primary structural similarities between types 5 and 24 M proteins of Streptococcus pyogenes. Biochem Biophys Res Commun (1980) 1.72
Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources. Antimicrob Agents Chemother (1976) 1.72
Immunochemical properties of streptococcal M protein purified by isoelectric focusing. J Immunol (1975) 1.72
Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun (1985) 1.71
Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J Exp Med (1986) 1.71
Superantigenicity of streptococcal M protein. J Exp Med (1990) 1.70
Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A (1984) 1.67
Hydrophobic interactions of group A streptococci with hexadecane droplets. J Bacteriol (1983) 1.67
Suppression of bacterial adherence by subminimal inhibitory concentrations of beta-lactam and aminoglycoside antibiotics. Rev Infect Dis (1980) 1.67
Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis (1988) 1.66
Erythrocyte binding properties of streptococcal lipoteichoic acids. Infect Immun (1979) 1.65
Interaction of lipoteichoic acid of group A streptococci with human platelets. Infect Immun (1977) 1.65
Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med (1985) 1.65